Lynkuet is the first FDA-approved therapy that blocks both the neurokinin 1 and neurokinin 3 receptors to treat hot flashes.
On Friday, the FDA approved Bayer’s dual neurokinin (NK) targeted therapy elinzanetant, which will now be marketed in the U.S ...
A myasthenia gravis treatment revolution has taken place in the past four years, spurred by an initial approval for argenx’s ...
Patients often smile or nod along. Salaysay even sees changes in their vital ... Acute pain is felt when pain receptors in a ...
Patients often smile or nod along. Salaysay even sees changes in their vital ... Acute pain is felt when pain receptors in a ...
Nurse Rod Salaysay works with all kinds of instruments in the hospital: a thermometer, a stethoscope and sometimes his guitar and ukulele.
Hospitals are using music to help patients manage pain. Studies show listening to preferred songs can reduce pain perception ...
Pharmaceutical Technology on MSN
Ventus and Genentech partner for small-molecule medicine discovery
The partnership includes an upfront payment to Ventus, with potential for additional milestone payments that could surpass $460m.
Clinical Trials Arena on MSN
ESMO 2025: Eli Lilly’s Verzenio extends survival in high-risk early breast cancer
These Phase III results could enhance Verzenio’s uptake alongside ET in the adjuvant breast cancer setting, if approved.
Hidden in the charming town of Bethlehem, Connecticut lies a bargain hunter’s utopia where your wallet stays fat and your shopping bags bulge—the Bethlehem Indoor Flea Market transforms modest budgets ...
Tucked away in Milwaukee’s bustling cityscape, Cafe India doesn’t scream for attention with flashy signs or gimmicks. Instead, it quietly goes about its business of serving some of the most authentic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results